U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula CBrN
Molecular Weight 105.921
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYANOGEN BROMIDE

SMILES

BrC#N

InChI

InChIKey=ATDGTVJJHBUTRL-UHFFFAOYSA-N
InChI=1S/CBrN/c2-1-3

HIDE SMILES / InChI

Molecular Formula CBrN
Molecular Weight 105.921
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
A fusion protein system for the recombinant production of short disulfide-containing peptides.
2002-10
Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin.
2002-10
Cyanogen bromide activation and coupling of ligands to diol-containing silica for high-performance affinity chromatography optimization of conditions.
2002-09-20
Combined in-gel tryptic digestion and CNBr cleavage for the generation of peptide maps of an integral membrane protein with MALDI-TOF mass spectrometry.
2002-09-10
The catalytic center of glucose-6-phosphatase. HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis.
2002-09-06
Sauvagine cross-links to the second extracellular loop of the corticotropin-releasing factor type 1 receptor.
2002-09-06
Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor.
2002-09
Pyrimidinethione nucleosides and their deaza analogues.
2002-08-17
Streptococcus sanguis modulates type II collagen-induced arthritis in DBA/1J mice.
2002-08-15
The epithelial mitogen keratinocyte growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline.
2002-07-26
Parallel solid-phase synthesis of trisubstituted triazinobenzimidazolediones.
2002-07-09
Induction of endolymphatic hydrops by directly infused monoclonal antibody against type II collagen CB11 peptide.
2002-07
Amino acid sequence of a thrombin like enzyme, elegaxobin, from the venom of Trimeresurus elegans (Sakishima-habu).
2002-07
Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus.
2002-06-07
Anti-bovine rhodopsin monoclonal antibody recognizing light-dependent structural change.
2002-06
Activation of erythropoietin receptor through a novel extracellular binding site.
2002-06
Coupling of ligand binding and dimerization of helix-loop-helix peptides: spectroscopic and sedimentation analyses of calbindin D9k EF-hands.
2002-05-15
Type II collagen deposition in cruciate ligament precedes osteoarthritis in the guinea pig knee.
2002-05
Primary structure and pathological study of phospholipase A2-I from Agkistrodon bilineatus (common cantil) venom.
2002-05
Short-term effects of forced eccentric contractions on collagen synthesis and degradation in rat skeletal muscle.
2002-05
Molecular dissection of membrane-transport proteins: mass spectrometry and sequence determination of the galactose-H+ symport protein, GalP, of Escherichia coli and quantitative assay of the incorporation of [ring-2-13C]histidine and (15)NH(3).
2002-04-15
Legumain from bovine kidney: its purification, molecular cloning, immunohistochemical localization and degradation of annexin II and vitamin D-binding protein.
2002-04-01
Replacement of cyanogen bromide solution PH. EUR. with 1,3-dibromo-5,5-dimethylhydantoin (DBH). Analytical methods of pharmacopoeias with DBH in respect to environmental and economical concern, Part 13.
2002-04
Thermodynamics of single peptide bond cleavage in bovine pancreatic trypsin inhibitor (BPTI).
2002-04
2-Trimethylsilylethyl sulfides in the von Braun cyanogen bromide reaction: selective preparation of thiocyanates and application to nucleoside chemistry.
2002-03-22
Stilbene photochrome-fluorescence-spin molecules: covalent immobilization on silica plate and applications as redox and viscosity probes.
2002-03-04
Phosphorylation of Xenopus transcription factor IIIA by an oocyte protein kinase CK2.
2002-03-01
Identification and characterization of hydrophobic Escherichia coli virulence proteins by liquid chromatography-electrospray ionization mass spectrometry.
2002-03-01
Insulin-like growth factor-I enhances cell-based repair of articular cartilage.
2002-03
Improved in-gel approaches to generate peptide maps of integral membrane proteins with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
2002-03
Affinity protection chromatography for efficient labeling of antibodies for use in affinity capillary electrophoresis.
2002-03
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen.
2002-03
Six-coordinate and five-coordinate Fe(II)(CN)(2)(CO)(x) thiolate complexes (x = 1, 2): synthetic advances for iron sites of [NiFe] hydrogenases.
2002-02-27
A solid-phase route to N-cyanoamides.
2002-02-21
Immobilized earthworm fibrinolytic enzyme III-1 with carbonyldiimidazole activated-agarose.
2002-02
Heat stress-induced loss of eukaryotic initiation factor 5A (eIF-5A) in a human pancreatic cancer cell line, MIA PaCa-2, analyzed by two-dimensional gel electrophoresis.
2002-02
DNA-support coupling for transcription factor purification. Comparison of aldehyde, cyanogen bromide and N-hydroxysuccinimide chemistries.
2002-01-04
Monoclonal antibodies recognizing epitopes of calretinins: dependence on Ca2+-binding status and differences in antigen accessibility in colon cancer cells.
2002-01
The primary structure of cassowary (Casuarius casuarius) goose type lysozyme.
2002-01
Insights into integrin-ligand binding and activation from the first crystal structure.
2002
Longitudinal variation in muscle protein expression and contraction kinetics of largemouth bass axial muscle.
2001-12
The glycan structure of albumin Redhill, a glycosylated variant of human serum albumin.
2001-11-26
A novel approach for the solid-phase synthesis of substituted cyclic guanidines, their respective bis analogues, and N-acylated guanidines from N-acylated amino acid amides.
2001-11-13
Removal of poliovirus type 1 from a protein mixture using an immunoaffinity chromatography column.
2001-11
Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator.
2001-11
DNA affinity chromatography.
2001-10
Improved accuracy in the matrix-assisted laser desorption/ionization-mass spectrometry determination of the molecular mass of cyanogen bromide fragments of proteins by post-cleavage reaction with tris(hydroxymethyl)aminomethane.
2001-08
Detection and localisation of disulphide bonds in a synthetic peptide reproducing the sequence 1-30 of Par j 1.0101 by electrospray ionisation mass spectrometry.
2001-08
Isolation and amino acid sequence of a serine proteinase inhibitor from common flax (Linum usitatissimum) seeds.
2001-01-08
NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:54:17 GMT 2025
Edited
by admin
on Mon Mar 31 19:54:17 GMT 2025
Record UNII
OS382OHJ8P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CYANOGEN BROMIDE
HSDB   MI  
Systematic Name English
NSC-89684
Preferred Name English
CYANOGEN BROMIDE [MI]
Common Name English
CYANOGEN BROMIDE ((CN)BR)
Common Name English
CYANOGEN BROMIDE [HSDB]
Common Name English
CYANOBROMIDE
Systematic Name English
BROMOCYANOGEN
Common Name English
BROMINE CYANIDE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID9021550
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
WIKIPEDIA
CYANOGEN BROMIDE
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
NCI_THESAURUS
C402
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
FDA UNII
OS382OHJ8P
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
HSDB
708
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
CAS
506-68-3
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
NSC
89684
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
CONCEPT Industrial Aid
PUBCHEM
10476
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-051-2
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
MERCK INDEX
m3953
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY Merck Index